Dhingra Kapil — SEC Form 4 filings
SEC reporting owner CIK 1456849. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-04-03 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,169 shares, $32,958 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 3,169 shares @ $10.40 ($32,958) in Replimune Group, Inc., filed 2025-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | Director | 4 | — | 1 leg · 3,169 sh · $32,958 | 5 |
| CARGO Therapeutics, Inc. (CRGX) | Director | 4 | — | — | 4 |
| Black Diamond Therapeutics, Inc. (BDTX) | Director | 3 | — | — | 3 |
| LAVA Therapeutics NV (LVTX) | Director | 2 | — | — | 3 |
Form 4 filings — Dhingra Kapil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 44,500 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Replimune Group, Inc. (REPL) | Option exercise (M): 3,169 @ $1.75 · Sale (S): 3,169 @ $10.40 · Option exercise (M): 3,169 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | LAVA Therapeutics NV (LVTX) | Disposition to issuer (D): 30,000 · Disposition to issuer (D): 33,390 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | CARGO Therapeutics, Inc. (CRGX) | Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2025-06-20 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 30,550 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | LAVA Therapeutics NV (LVTX) | Grant/award (A): 33,390 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 30,550 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 11,871 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | CARGO Therapeutics, Inc. (CRGX) | Grant/award (A): 49,265 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1456849 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →